Merck ends study of cholesterol drug

This is a discussion on Merck ends study of cholesterol drug within the Other Healthcare Law Issues forum, part of the HEALTHCARE LAW & MALPRACTICE category; Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging ...

Consult Your Own Personal Lawyer Now!
Reply

 

Thread Tools Search this Thread Rate Thread Display Modes
Old May 22nd, 2008, 06:50 AM   #1
ria
Guest
 

ria's Avatar
 
Posts: n/a

Default Merck ends study of cholesterol drug

Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug.

The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after the same scientists urged enrollment of more patients be put on hold. MK-0524A combines the B vitamin niacin and a drug called laropiprant to limit the facial flushing caused by niacin.

The halted study, called ACHIEVE, used ultrasound imaging to monitor plaque buildup in arteries of people whose genes give them sky-high cholesterol levels — the same kind of patients and technology in a study of Merck's popular Vytorin cholesterol drug that backfired earlier this year.

Epharma - Landing Page

Last edited by top_admin; May 22nd, 2008 at 07:02 AM.
  Reply With Quote
Reply

Bookmark & Share

Tags
None



Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes Rate This Thread
Rate This Thread:

| More

Posting Rules
You may post new threads
You may post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are Off
Pingbacks are Off
Refbacks are Off

Format Your Messages
Add Forum to Google Toolbar
Forum Jump

Similar Threads

Thread Thread Starter Forum Replies Last Post
Merck Closes Yet Another Chapter in the Vioxx Nightmare WSJ Law Blog Law News 0 Feb 11th, 2010 10:10 AM
drug addiction, drug addicts & drug rehabs jenniferchristy Dangerous Drugs & Medical Devices 4 Dec 26th, 2009 07:00 AM
COME STUDY IN UKRAINE, STUDY ABROAD Bancompany Other Immigration Law & Visas 1 Dec 1st, 2009 04:55 PM
A Post-Game Report on the Merck-Vioxx Reversals WSJ Law Blog Class Actions & Defective Products 0 May 30th, 2008 10:30 AM
Merck Scores More Vioxx Wins; Did it Reach its Big Settlement too Soon? WSJ Law Blog Class Actions & Defective Products 0 May 29th, 2008 02:00 PM


International Law Issues?


All times are GMT -4. The time now is 06:08 PM.